Clinical Trial Update: Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the levonorgestrel-releasing intrauterine system with or without everolimus to treat atypical endometrial hyperplasia and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Endometrial Hyperplasia
• Endometrial Cancer

Drugs mentioned

• Everolimus (everolimus)
• Levonorgestrel-Releasing Intrauterine System (levonorgestrel-releasing intrauterine system)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Atypical Endometrial Hyperplasia, FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING